GlassScriptPhysician profile
Herman M Teachey
NPI 1336236686
$1,172.29
in general payments reported to CMS, 2019-2025
12 companies · $90.40 in 2025
The $90.40 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.43 · 2021: $295 · 2022: $317 · 2023: $221 · 2024: $238 · 2025: $90.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $328.39 | 2021-2022 | |
| Genzyme Corporation | $256.14 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $172.46 | 2021-2023 | Dupixent |
| Smith+Nephew, INC. | $97.47 | 2024-2025 | Halo, Rf20000, Ent Sinus |
| Depuy Synthes Sales INC. | $92.24 | 2023 | Matrixmandible |
| Kerecis Limited | $70.82 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Merck Sharp & Dohme LLC | $48.51 | 2022-2023 | |
| Integra Lifesciences Corporation | $39.82 | 2022-2023 | Microfrance, Codman Isocool Aht, Integra |
| Optinose US, INC. | $24.72 | 2024 | |
| Glaxosmithkline, LLC. | $18.54 | 2022 | |
| Hologic Sales and Service, LLC | $11.75 | 2022 | |
| Intersect Ent, INC. | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herman Teachey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.